HIMS - Elliot 'C' Wave Short HIMS has reached its A wave retrace of >.786 (i.e. 'B' wave is complete). Started short today. Will cover short when price < $19, or price > $31.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.47 USD
−23.55 M USD
872.00 M USD
177.25 M
About Hims & Hers Health, Inc.
Sector
Industry
CEO
Andrew Dudum
Website
Headquarters
San Francisco
Founded
2017
FIGI
BBG00Q53VYM7
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.
My HIGHFIVESETUP Indicator in action on HIMS. Massive gains!My HIGHFIVESETUP Indicator in action on $HIMS. Massive gains!
Check out my HIGH-FIVE SETUP trading strategy indicator in action on NYSE:HIMS stock over the last two years!
Over 200% gains based on a $10k starting account.
- $10k into $31.5k+
- Almost a 90% accuracy based on the buys and sells.
HIMS:Potential HNS Pattern / HTF Double top Pattern NYSE:HIMS Analysis and Key Levels
Greetings Everyone,
After an impressive 400% rally from its October 2023 lows, HIMS is now showing potential signs of weakness.
Currently, the stock is trading below a key resistance/pivot zone (marked by the orange box) between $23.47 and $25.34. While thi
$HIMS: OUTLOOK NYSE:HIMS : OUTLOOK
This may just be the START for $HIMS!
We could see a BREAKOUT here, and it could really take off!🚀
There’s also an INSANE amount of hype right now.
👉 LIKE & FOLLOW for more updates!
DON'T SELL HIMS UNTIL YOU WATCH THIS FIRST!DON'T SELL YOUR NYSE:HIMS SHARES UNTIL YOU WATCH THIS FIRST🛑
In this video, we will discuss:
-Why you shouldn't sell on the NASDAQ:AMZN health news
-Amazons multiple failed business adventures
-How NYSE:HIMS is still ok even if Amazon is successful
-Fundamental and Technical analysis
You wi
$HIMS - Still no touch for me.NYSE:HIMS Amazon is starting to sell cheap hair-loss drugs. BofA downgraded the stock from Buy to Underperform. The stock reacted with a 25% drop.
I had always been concerned about the threat from Amazon, along with legal and regulatory issues for this stock.
I don't think Amazon will stop at jus
11/14/24 - $hims - Don't overthink it. Buy ~$20.11/14/24 :: VROCKSTAR :: NYSE:HIMS
Don't overthink it. Buy ~$20.
- great traction
- cash generating
- 20 PE on my #s, 22x on consensus for 20% growth
- no major stock based comp issue
- stock highly rented (call options) by fintwit
- Walmart entering their market is MORE CONFIRMATION that they're
GLP1 shortage overHIMS is a major player in the compounded semaglutide space. It spent hundreds of millions to promote their offering in the weight loss space, making use of the shortage in Ozempic and other GLP1s in recent months. The company's offerings include semaglutide-based injections, marketed as containing t
FOMO INTO $HIMS YOU WILL! Should have listened. FOMO INTO NYSE:HIMS YOU WILL! Should have listened.
In this video analysis, we will go over:
1⃣ My #HIGHFIVESETUP
2⃣ CUP N HANDLE BREAKOUT
3⃣ Trade ideas, including Entry/Exit/PT's
4⃣ ...Find out in the video below
NFA
$HIMS Elliot WaveTrying out some Elliot wave counts. I believe we are in an extended third wave right now with a target of $45 long term
Mid term $35
Hopefully ER might give us a boost towards the mid term targets.
NFA, not a professional, still learning. What do you guys think
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of HIMS is 30.34 USD — it hasn't changed in the past 24 hours. Watch Hims & Hers Health, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Hims & Hers Health, Inc. stocks are traded under the ticker HIMS.
HIMS stock has risen by 33.10% compared to the previous week, the month change is a 36.60% rise, over the last year Hims & Hers Health, Inc. has showed a 268.65% increase.
We've gathered analysts' opinions on Hims & Hers Health, Inc. future price: according to them, HIMS price has a max estimate of 32.00 USD and a min estimate of 18.00 USD. Watch HIMS chart and read a more detailed Hims & Hers Health, Inc. stock forecast: see what analysts think of Hims & Hers Health, Inc. and suggest that you do with its stocks.
HIMS reached its all-time high on Nov 13, 2024 with the price of 30.44 USD, and its all-time low was 2.72 USD and was reached on May 12, 2022. View more price dynamics on HIMS chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
HIMS stock is 16.62% volatile and has beta coefficient of 3.49. Track Hims & Hers Health, Inc. stock price on the chart and check out the list of the most volatile stocks — is Hims & Hers Health, Inc. there?
Today Hims & Hers Health, Inc. has the market capitalization of 6.63 B, it has increased by 25.00% over the last week.
Yes, you can track Hims & Hers Health, Inc. financials in yearly and quarterly reports right on TradingView.
Hims & Hers Health, Inc. is going to release the next earnings report on Mar 3, 2025. Keep track of upcoming events with our Earnings Calendar.
HIMS earnings for the last quarter are 0.32 USD per share, whereas the estimation was 0.11 USD resulting in a 187.74% surprise. The estimated earnings for the next quarter are 0.18 USD per share. See more details about Hims & Hers Health, Inc. earnings.
Hims & Hers Health, Inc. revenue for the last quarter amounts to 401.56 M USD, despite the estimated figure of 382.20 M USD. In the next quarter, revenue is expected to reach 469.32 M USD.
HIMS net income for the last quarter is 75.59 M USD, while the quarter before that showed 13.30 M USD of net income which accounts for 468.46% change. Track more Hims & Hers Health, Inc. financial stats to get the full picture.
No, HIMS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 28, 2024, the company has 1.05 K employees. See our rating of the largest employees — is Hims & Hers Health, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Hims & Hers Health, Inc. EBITDA is 50.21 M USD, and current EBITDA margin is −2.75%. See more stats in Hims & Hers Health, Inc. financial statements.
Like other stocks, HIMS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Hims & Hers Health, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Hims & Hers Health, Inc. technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Hims & Hers Health, Inc. stock shows the strong buy signal. See more of Hims & Hers Health, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.